Evidence map›Paper›PMID 21277919›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2011

Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions.

Natalya Rapoport, Kweon-Ho Nam, Roohi Gupta, Zhongao Gao, Praveena Mohan, Allison Payne, Nick Todd, Xin Liu, Taeho Kim, Jill Shea and 4 more

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 170 papers.

0numbers the graph read from it
0cells of the map it votes in
170citing papers in PubMed
18.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

170 citing papers in PubMed, 420 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Non-Ionic Fluorosurfactants for Droplet-Based in vivo Applications.Angewandte Chemie (International ed. in English) · 2024
    Article
  10. Remotely controlled drug release in deep brain regions of non-human primates.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Acoustomechanically activatable liposomes for ultrasonic drug uncaging.bioRxiv : the preprint server for biology · 2023
    Article
  19. Article
  20. Article

110 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Natalya RapoportDepartment of Bioengineering, University of Utah, Salt Lake City, UT 84112, USA. natasha.rapoport@utah.edu
Kweon-Ho Nam
Roohi Gupta
Zhongao Gao
Praveena Mohan
Allison Payne
Nick Todd
Xin Liu
Taeho Kim
Jill Shea
Courtney Scaife
Dennis L Parker
Eun-Kee Jeong
Anne M Kennedy
University of Utah · USAdvanced Imaging Research (United States) · USChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

Acoustically Activated Micellar Drug DeliveryR01EB001033 · NIBIB · UNIVERSITY OF UTAH · PI RAPOPORT, NATALYA Y · 2002 to 2010
$2.1M
Acoustically Activated Micellar Drug DeliveryR56EB001033 · NIBIB · UNIVERSITY OF UTAH · PI RAPOPORT, NATALYA Y · 2007 to 2007
$351k
NIBIB NIH HHS R01 EB001033NIBIB NIH HHS R01EB001033NIBIB NIH HHS R56 EB001033NIBIB NIH HHS R56EB001033
6 · The paper itself

Abstract

Perfluorocarbon nanoemulsions can deliver lipophilic therapeutic agents to solid tumors and simultaneously provide for monitoring nanocarrier biodistribution via ultrasonography and/or (19)F MRI. In the first generation of block copolymer stabilized perfluorocarbon nanoemulsions, perfluoropentane (PFP) was used as the droplet forming compound. Although manifesting excellent therapeutic and ultrasound imaging properties, PFP nanoemulsions were unstable at storage, difficult to handle, and underwent hard to control phenomenon of irreversible droplet-to-bubble transition upon injection. To solve the above problems, perfluoro-15-crown-5-ether (PFCE) was used as a core forming compound in the second generation of block copolymer stabilized perfluorocarbon nanoemulsions. PFCE nanodroplets manifest both ultrasound and fluorine ((19)F) MR contrast properties, which allows using multimodal imaging and (19)F MR spectroscopy for monitoring nanodroplet pharmacokinetics and biodistribution. In the present paper, acoustic, imaging, and therapeutic properties of unloaded and paclitaxel (PTX) loaded PFCE nanoemulsions are reported. As manifested by the (19)F MR spectroscopy, PFCE nanodroplets are long circulating, with about 50% of the injected dose remaining in circulation 2h after the systemic injection. Sonication with 1-MHz therapeutic ultrasound triggered reversible droplet-to-bubble transition in PFCE nanoemulsions. Microbubbles formed by acoustic vaporization of nanodroplets underwent stable cavitation. The nanodroplet size (200nm to 350nm depending on a type of the shell and conditions of emulsification) as well as long residence in circulation favored their passive accumulation in tumor tissue that was confirmed by ultrasonography. In the breast and pancreatic cancer animal models, ultrasound-mediated therapy with paclitaxel-loaded PFCE nanoemulsions showed excellent therapeutic properties characterized by tumor regression and suppression of metastasis. Anticipated mechanisms of the observed effects are discussed.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicBreast NeoplasmsCell Line, TumorDrug Delivery SystemsEmulsionsFemaleFluorocarbonsHumansMiceNanomedicineNeoplasmsPaclitaxelPancreatic NeoplasmsUltrasonic TherapyUltrasonographyAntineoplastic Agents, PhytogenicEmulsionsFluorocarbonsPaclitaxel

Identifiers

PMID21277919
PMCPMC3133819
OpenAlexW2061501935

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.